| # | Drug | Count |
|---|---|---|
| 0 | ETELCALCETIDE | 128 |
| 1 | DARBEPOETIN ALFA | 106 |
| 2 | LANTHANUM CARBONATE | 106 |
| 3 | ANTACID | 34 |
| 4 | CALCIUM CARBONATE | 34 |
| 5 | FUROSEMIDE | 34 |
| 6 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 34 |
| 7 | PARICALCITOL | 28 |
| 8 | ASPIRIN | 24 |
| 9 | IRON SUCROSE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETELCALCETIDE | 128 | 0.0445 |
| 1 | LANTHANUM CARBONATE | 106 | 0.0207 |
| 2 | DAPRODUSTAT | 16 | 0.0080 |
| 3 | SUCROFERRIC OXYHYDROXIDE | 22 | 0.0072 |
| 4 | SEVELAMER HYDROCHLORIDE | 4 | 0.0070 |
| 5 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 6 | VADADUSTAT | 2 | 0.0065 |
| 7 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 8 | TENAPANOR HYDROCHLORIDE | 15 | 0.0040 |
| 9 | PEGVISOMANT | 15 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 106 |
| 1 | Loop Diuretic [EPC] | 40 |
| 2 | Corticosteroid [EPC] | 34 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 4 | Parenteral Iron Replacement [EPC] | 30 |
| 5 | Vitamin D Analog [EPC] | 28 |
| 6 | Vitamin D2 Analog [EPC] | 28 |
| 7 | beta-Adrenergic Blocker [EPC] | 27 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 26 |
| 9 | Proton Pump Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 18 | 0.0079 |
| 1 | Phosphate Binder [EPC] | 22 | 0.0072 |
| 2 | Vitamin D2 Analog [EPC] | 28 | 0.0039 |
| 3 | Parenteral Iron Replacement [EPC] | 30 | 0.0022 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 106 | 0.0020 |
| 5 | Vitamin D Analog [EPC] | 28 | 0.0016 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 7 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 8 | Vitamin D3 Analog [EPC] | 23 | 0.0011 |
| 9 | Chloride Channel Activator [EPC] | 7 | 0.0007 |